PD 089828

CAS No. 179343-17-0

PD 089828 ( PD-089828; PD089828 )

Catalog No. M23806 CAS No. 179343-17-0

PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 In Stock
10MG 110 In Stock
25MG 237 In Stock
50MG 354 In Stock
100MG 518 In Stock
500MG 1098 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD 089828
  • Note
    Research use only, not for human use.
  • Brief Description
    PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
  • Description
    PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
  • Synonyms
    PD-089828; PD089828
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR;FGFR1;PDGFRβ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    179343-17-0
  • Formula Weight
    405.3
  • Molecular Formula
    C18H18Cl2N6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:2.5 mM
  • SMILES
    CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=C(C=CC=C3Cl)Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dahring TK, et al. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor. J Pharmacol Exp Ther. 1997 Jun;281(3):1446-56.
molnova catalog
related products
  • EGFR/ErbB2 Inhibitor

    EGFR/ErbB2 Inhibitor is a cell-permeable inhibitor of EGFR and c-ErbB2 (IC50s = 20 and 79 nM, respectively)

  • Naquotinib mesylate

    Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.

  • Epidermal Growth Fac...

    Epidermal Growth Factor?binds to epidermal growth factor receptor (EGFR) and stimulates cell growth and proliferation. It is approved for the treatment of diabetic foot ulcers.